Melanoma Center, Department of Dermatology, University of California, San Francisco, 1600 Divisadero St, Fourth Floor, San Francisco, CA 94143-1706, USA.
J Am Acad Dermatol. 2010 May;62(5):751-6. doi: 10.1016/j.jaad.2009.09.043. Epub 2010 Mar 19.
Histopathologic analysis remains the gold standard for the pathologic diagnosis of melanoma. Numerous histologic criteria are used to diagnose melanoma, but none alone are sufficient to establish this diagnosis. Therefore, differentiating between benign pigmented lesions and melanoma may be controversial. Although several studies have examined the interobserver variability in the pathological diagnosis of melanoma, the prevalence of discordant diagnoses of melanocytic neoplasms is unknown.
We sought to examine the discordance rate of melanoma diagnoses referred to our pigmented lesion clinic, a subset of the University of California, San Francisco (UCSF) Department of Dermatology and Comprehensive Cancer Center Melanoma Center during a 2-year period.
A total of 392 new patients given a diagnosis of thin melanoma (melanoma in situ, stage IA, stage IB) or benign nevus were referred in 2006 and 2007, with initial diagnoses rendered by an outside dermatopathologist or surgical pathologist. Subsequently, these specimens were re-evaluated by routine histopathologic examination at the UCSF Dermatopathology Service and a distinct diagnosis was rendered. The two available diagnoses were compared, and discordance was defined as the lack of agreement between two pathologists when rendering a benign versus malignant versus ambiguous diagnosis.
The discordance rate of melanomas and nevi between the referring centers and UCSF was 14.3%.
This review was limited in that there were few patients with benign pigmented lesions referred to the pigmented lesion clinic at UCSF.
The level of discordance in the routine histopathologic interpretation of melanocytic neoplasms can be high.
组织病理学分析仍然是黑色素瘤病理诊断的金标准。有许多组织学标准可用于诊断黑色素瘤,但没有任何一个标准足以单独建立该诊断。因此,良性色素病变与黑色素瘤之间的区分可能存在争议。尽管有几项研究检查了黑色素瘤病理诊断的观察者间变异性,但黑素细胞肿瘤的不一致诊断的患病率尚不清楚。
我们旨在检查我们色素病变诊所(加利福尼亚大学旧金山分校(UCSF)皮肤科和综合癌症中心黑色素瘤中心的一部分)在 2 年期间转介的黑色素瘤诊断的不一致率。
2006 年和 2007 年共转介了 392 例新诊断为薄型黑色素瘤(原位黑色素瘤,IA 期,IB 期)或良性痣的患者,最初的诊断由外部皮肤科病理学家或外科病理学家做出。随后,这些标本在 UCSF 皮肤病理服务处进行常规组织病理学检查重新评估,并给出明确的诊断。比较了两种可用的诊断,分歧定义为当做出良性与恶性与模棱两可的诊断时,两位病理学家之间的不一致。
转诊中心和 UCSF 之间黑色素瘤和痣的分歧率为 14.3%。
本综述的局限性在于,UCSF 色素病变诊所转介的良性色素病变患者很少。
黑素细胞肿瘤的常规组织病理学解释中的分歧程度可能很高。